A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban.
about
A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A post-marketing assessment of ...... atients receiving rivaroxaban.
@en
A post-marketing assessment of ...... atients receiving rivaroxaban.
@nl
type
label
A post-marketing assessment of ...... atients receiving rivaroxaban.
@en
A post-marketing assessment of ...... atients receiving rivaroxaban.
@nl
prefLabel
A post-marketing assessment of ...... atients receiving rivaroxaban.
@en
A post-marketing assessment of ...... atients receiving rivaroxaban.
@nl
P2093
P2860
P1476
A post-marketing assessment of ...... atients receiving rivaroxaban.
@en
P2093
Alexander G G Turpie
Kathleen Pillsbury Hopf
Louis M Kwong
Manesh R Patel
Nicholas Sicignano
Sally Tamayo
W Frank Peacock
Zhong Yuan
P2860
P304
P356
10.1080/03007995.2017.1351935
P407
P577
2017-07-05T00:00:00Z